methylergonovine maleate
(Methylergonovine Maleate)Teva Pharmaceuticals USA, Inc.
Usage: This drug is indicated for the routine management of uterine atony, hemorrhage, and subinvolution of the uterus following placenta delivery, as well as for controlling uterine hemorrhage during the second stage of labor after the delivery of the anterior shoulder.